Search Results - "Strutton, David R."

Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data.

Authors: Strutton, David R. Farkouh, Raymond A. Rubin, Jaime L. et al.

Source: BMC Infectious Diseases. 2012, Vol. 12 Issue 1, p175-178. 4p. 2 Charts.

Influence of medication treatment patterns on resource use for patients hospitalized for schizophrenia.

Authors: Strutton, David R. Gutierrez, Benjamin Blanchette, Christopher M.

Source: American Journal of Health-System Pharmacy. 1/1/2008, Vol. 65 Issue 1, p42-48. 7p. 5 Charts.

Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations

Authors: Snedecor, Sonya J. Strutton, David R. Ciuryla, Vincent et al.

Source: Vaccine. Jul2009, Vol. 27 Issue 34, p4694-4703. 10p.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine

Authors: Isaacman, Daniel J. Strutton, David R. Kalpas, Edward A. et al.

Source: Clinical Therapeutics. Feb2008, Vol. 30 Issue 2, p341-357. 17p.

Impact of smoking on respiratory illness—related outpatient visits among 50- to 75-year-olds in the United States

Authors: Hoffman, Lynn H. Strutton, David R. Stang, Paul E. et al.

Source: Clinical Therapeutics. Feb2002, Vol. 24 Issue 2, p317. 8p.

Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions.

Authors: Weycker, Derek Farkouh, Raymond A. Strutton, David R. et al.

Source: BMC Health Services Research. 5/13/2016, Vol. 16, p1-10. 10p. 3 Charts, 3 Graphs.

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

Authors: Rubin, Jaime L. McGarry, Lisa J. Strutton, David R. et al.

Source: Vaccine. Nov2010, Vol. 28 Issue 48, p7634-7643. 10p.

Rates of pneumonia among children and adults with chronic medical conditions in Germany.

Authors: Pelton, Stephen I. Shea, Kimberly M. Farkouh, Raymond A. et al.

Source: BMC Infectious Diseases. 10/30/2015, Vol. 15, p1-8. 8p. 2 Charts, 2 Graphs.

Despite High Cost, Improved Pneumococcal Vaccine Expected To Return 10-Year Net Savings Of $12 Billion.

Authors: Kohli, Michele A. Farkouh, Raymond A. Maschio, Michael J. et al.

Source: Health Affairs. Jul2015, Vol. 34 Issue 7, p1234-1240. 7p.

Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States.

Authors: McGarry, Lisa J. Gilmore, Kristen E. Rubin, Jaime L. et al.

Source: BMC Infectious Diseases. 2013, Vol. 13 Issue 1, p1-11. 11p. 3 Charts, 1 Graph.

Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic.

Authors: Rubin, Jaime L McGarry, Lisa J. Klugman, Keith P. et al.

Source: BMC Infectious Diseases. 2010, Vol. 10 Issue 1, Special section p1-11. 11p. 1 Diagram, 3 Charts.

Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine.

Authors: Pelton, Stephen I. Weycker, Derek Farkouh, Raymond A. et al.

Source: Clinical Infectious Diseases. Sep2014, Vol. 59 Issue 5, p615-623. 9p.

Letter to the Editor.

Authors: Westra, Tjalke A. Fortanier, Sander C. Delgleize, Emmanuelle et al.

Source: Clinical Therapeutics. 2013, Vol. 35 Issue 7, p1046-1050. 5p.

Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden.

Authors: Klok, Rogier M. Lindkvist, Rose-Marie Ekelund, Mats et al.

Source: Clinical Therapeutics. 2013, Vol. 35 Issue 2, p119-134. 16p.

Cost-effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States

Authors: Ray, G. Thomas Pelton, Stephen I. Klugman, Keith P. et al.

Source: Vaccine. Nov2009, Vol. 27 Issue 47, p6483-6494. 12p.

Letter to the editor.

Authors: Klok RM Lindkvist RM Ekelund M et al.

Source: Clinical therapeutics [Clin Ther] 2013 Jul; Vol. 35 (7), pp. 1048-50. Date of Electronic Publication: 2013 Jun 24.

Publication Type: Letter; Comment

Journal Info: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE

Rethinking risk for pneumococcal disease in adults: the role of risk stacking.

Authors: Pelton SI Shea KM Weycker D et al.

Source: Open forum infectious diseases [Open Forum Infect Dis] 2015 Mar 20; Vol. 2 (1), pp. ofv020. Date of Electronic Publication: 2015 Mar 20 (Print Publication: 2015).

Publication Type: Journal Article

Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Rates of pneumococcal disease in adults with chronic medical conditions.

Authors: Shea KM Edelsberg J Weycker D et al.

Source: Open forum infectious diseases [Open Forum Infect Dis] 2014 May 27; Vol. 1 (1), pp. ofu024. Date of Electronic Publication: 2014 May 27 (Print Publication: 2014).

Publication Type: Journal Article

Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions.

Authors: Farkouh RA Klok RM Postma MJ et al.

Source: Expert review of vaccines [Expert Rev Vaccines] 2012 Oct; Vol. 11 (10), pp. 1235-47. Date of Electronic Publication: 2012 Nov 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.

Authors: Strutton DR Farkouh RA Earnshaw SR et al.

Source: The Journal of infection [J Infect] 2012 Jan; Vol. 64 (1), pp. 54-67. Date of Electronic Publication: 2011 Nov 04.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE